Catalase Activity is Critical for Proteus mirabilis Biofilm Development, Extracellular Polymeric Substance Composition, and Dissemination during Catheter-Associated Urinary Tract Infection.
Ashley N WhiteBrian S LearmanAimee L BrauerChelsie E ArmbrusterPublished in: Infection and immunity (2021)
Proteus mirabilis is a leading uropathogen of catheter-associated urinary tract infections (CAUTIs), which are among the most common health care-associated infections worldwide. A key factor that contributes to P. mirabilis pathogenesis and persistence during CAUTI is the formation of catheter biofilms, which provide increased resistance to antibiotic treatment and host defense mechanisms. Another factor that is important for bacterial persistence during CAUTI is the ability to resist reactive oxygen species (ROS), such as through the action of the catalase enzyme. Potent catalase activity is one of the defining biochemical characteristics of P. mirabilis, and the single catalase (katA) gene in strain HI4320 was recently identified as a candidate fitness factor for UTI, CAUTI, and bacteremia. Here, we show that disruption of katA results in increased ROS levels, increased sensitivity to peroxide, and decreased biofilm biomass. The biomass defect was due to a decrease in the production of extracellular polymeric substances (EPS) by the ΔkatA mutant and specifically due to reduced carbohydrate content. Importantly, the biofilm defect resulted in decreased antibiotic resistance in vitro and a colonization defect during experimental CAUTI. The ΔkatA mutant also exhibited decreased fitness in a bacteremia model, supporting a dual role for catalase in P. mirabilis biofilm development and immune evasion.
Keyphrases
- urinary tract infection
- candida albicans
- pseudomonas aeruginosa
- reactive oxygen species
- staphylococcus aureus
- biofilm formation
- healthcare
- drug delivery
- body composition
- physical activity
- ultrasound guided
- dna damage
- cystic fibrosis
- wastewater treatment
- gram negative
- cancer therapy
- drug release
- drinking water
- wild type
- genome wide
- transcription factor
- combination therapy
- oxidative stress
- health insurance
- replacement therapy
- affordable care act